CIC
PVLA

Cornercap Investment Counsel’s Palvella Therapeutics PVLA Stock Holding History

Cornercap Investment Counsel’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-485
Closed -$45K – 653
2022
Q3 		$45K Hold
485
– – 0.01% 530
2022
Q2 		$72K Buy
+485
New +$88.5K 0.01% 536

Other funds holding PVLA

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Cornercap Investment Counsel's PVLA Position: Q4 2022 in Review

Cornercap Investment Counsel sold out of Palvella Therapeutics (PVLA) in Q4 2022, closing a stake of 485 shares — an estimated $45K sold.

Cornercap Investment Counsel first reported a position in PVLA in Q2 2022 and held it in 2 quarters. The position peaked at $72K in Q2 2022. 63 funds tracked by Wall St. Rank hold PVLA as of Q4 2022.

  • Cornercap Investment Counsel reported no remaining Palvella Therapeutics position as of Q4 2022 after selling out during the quarter.
  • Cornercap Investment Counsel sold 485 Palvella Therapeutics shares in Q4 2022, an estimated $45K.
  • Cornercap Investment Counsel first reported a position in Palvella Therapeutics in Q2 2022 and held it in 2 quarters.
  • Cornercap Investment Counsel's Palvella Therapeutics position peaked at $72K in Q2 2022.
  • 63 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q4 2022.

Based on Cornercap Investment Counsel's 13F filing for Q4 2022, filed 13 Feb 2023.